Resources Contact Us Home
Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof

Image Number 14 for United States Patent #8106164.

The invention pertains to the development of antibodies that specifically bind amyloid beta protein (Abeta) in its protofibril conformation. The invention also comprises methods of using anti-Abeta protofibril antibodies to diagnose or treat Alzheimer's disease, Down's syndrome Lewybody dementia, vascular dementia, and other neurodegenerative disorders. Furthermore, the invention pertains to the use of anti-Abeta protofibril antibodies to screen and identify substances that will modulate protofibril activity or formation in vitro or in vivo. The invention also pertains to methods for synthesising pure Abeta protofibril antigens as well as to a method for stabilising Abeta protofibrils antigens as well as to a method for stabilising Abeta protofibrils.

  Recently Added Patents
Semiconductor device with hetero-junction bodies
Image sensor and method for fabricating the same
Stable aqueous composite compositions
Sub-LUN input/output profiling for SSD devices
Dithering method and apparatus
Power device and method of packaging same
MIM capacitor and associated production method
  Randomly Featured Patents
Vehicle seat
Method for communicating data in xDSL using data retransmission
Machine for manufacturing structural members by braiding threads, and structural members obtained thereby
Nucleic acid encoding .alpha. chain of human IL-11 receptor
Conveyor with profiled cheeks
Firing tray
Managing power on integrated circuits using power islands
Motor starting circuit
Underpants with smooth sides